Global Chinese Patent Medicine Market Insights, Forecast to 2026
Chinese Patent Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chinese Patent Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Chinese Patent Medicine market is segmented into
The Chinese Patent Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chinese Patent Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chinese Patent Medicine Market Share Analysis
Chinese Patent Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chinese Patent Medicine business, the date to enter into the Chinese Patent Medicine market, Chinese Patent Medicine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Chinese Patent Medicine market is segmented into
- Syrup
- Liquid
- Tablet
- Others
- Online Sales
- Offline Sales
The Chinese Patent Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chinese Patent Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chinese Patent Medicine Market Share Analysis
Chinese Patent Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chinese Patent Medicine business, the date to enter into the Chinese Patent Medicine market, Chinese Patent Medicine product introduction, recent developments, etc.
The major vendors covered:
- Shanghai Pharmaceutical (Group) Co., Ltd.
- China Pharmaceutical Group Corporation
- Guangzhou Pharmaceutical Group Co., Ltd.
- Tianjin Pharmaceutical Group Co., Ltd.
- Harbin Pharmaceutical Group Co., Ltd
- Nanjing Pharmaceutical Industry (Group) Co., Ltd.
- North China Pharmaceutical Group Co., Ltd.
- Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
- Taiji Group Co., Ltd.
- Xinhualu Anti-Pharmaceutical Group Co., Ltd.
- Nanjing Pharmaceutical Co., Ltd
- Chongqing Pharmaceutical Co., Ltd
- Hangzhou Huadong Pharmaceutical Group Co., Ltd.
- Jiangxi Pharmaceutical Group Corporation
- Shijiazhuang Pharmaceutical Group Co., Ltd.
- Northeast Pharmaceutical Group Co., Ltd.
1 STUDY COVERAGE
1.1 Chinese Patent Medicine Product Introduction
1.2 Market Segments
1.3 Key Chinese Patent Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chinese Patent Medicine Market Size Growth Rate by Type
1.4.2 Syrup
1.4.3 Liquid
1.4.4 Tablet
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chinese Patent Medicine Market Size Growth Rate by Application
1.5.2 Online Sales
1.5.3 Offline Sales
1.6 Coronavirus Disease 2019 (Covid-19): Chinese Patent Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Chinese Patent Medicine Industry
1.6.1.1 Chinese Patent Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chinese Patent Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chinese Patent Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Chinese Patent Medicine Market Size Estimates and Forecasts
2.1.1 Global Chinese Patent Medicine Revenue 2015-2026
2.1.2 Global Chinese Patent Medicine Sales 2015-2026
2.2 Chinese Patent Medicine Market Size by Region: 2020 Versus 2026
2.2.1 Global Chinese Patent Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chinese Patent Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL CHINESE PATENT MEDICINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Chinese Patent Medicine Sales by Manufacturers
3.1.1 Chinese Patent Medicine Sales by Manufacturers (2015-2020)
3.1.2 Chinese Patent Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Chinese Patent Medicine Revenue by Manufacturers
3.2.1 Chinese Patent Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Chinese Patent Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chinese Patent Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chinese Patent Medicine Revenue in 2019
3.2.5 Global Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chinese Patent Medicine Price by Manufacturers
3.4 Chinese Patent Medicine Manufacturing Base Distribution, Product Types
3.4.1 Chinese Patent Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chinese Patent Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Chinese Patent Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Chinese Patent Medicine Market Size by Type (2015-2020)
4.1.1 Global Chinese Patent Medicine Sales by Type (2015-2020)
4.1.2 Global Chinese Patent Medicine Revenue by Type (2015-2020)
4.1.3 Chinese Patent Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chinese Patent Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Chinese Patent Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Chinese Patent Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Chinese Patent Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chinese Patent Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Chinese Patent Medicine Market Size by Application (2015-2020)
5.1.1 Global Chinese Patent Medicine Sales by Application (2015-2020)
5.1.2 Global Chinese Patent Medicine Revenue by Application (2015-2020)
5.1.3 Chinese Patent Medicine Price by Application (2015-2020)
5.2 Chinese Patent Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Chinese Patent Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Chinese Patent Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Chinese Patent Medicine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Chinese Patent Medicine by Country
6.1.1 North America Chinese Patent Medicine Sales by Country
6.1.2 North America Chinese Patent Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chinese Patent Medicine Market Facts & Figures by Type
6.3 North America Chinese Patent Medicine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Chinese Patent Medicine by Country
7.1.1 Europe Chinese Patent Medicine Sales by Country
7.1.2 Europe Chinese Patent Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chinese Patent Medicine Market Facts & Figures by Type
7.3 Europe Chinese Patent Medicine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Chinese Patent Medicine by Region
8.1.1 Asia Pacific Chinese Patent Medicine Sales by Region
8.1.2 Asia Pacific Chinese Patent Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chinese Patent Medicine Market Facts & Figures by Type
8.3 Asia Pacific Chinese Patent Medicine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Chinese Patent Medicine by Country
9.1.1 Latin America Chinese Patent Medicine Sales by Country
9.1.2 Latin America Chinese Patent Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chinese Patent Medicine Market Facts & Figures by Type
9.3 Central & South America Chinese Patent Medicine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Chinese Patent Medicine by Country
10.1.1 Middle East and Africa Chinese Patent Medicine Sales by Country
10.1.2 Middle East and Africa Chinese Patent Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chinese Patent Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Chinese Patent Medicine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Shanghai Pharmaceutical (Group) Co., Ltd.
11.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
11.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Description, Business Overview and Total Revenue
11.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Products Offered
11.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development
11.2 China Pharmaceutical Group Corporation
11.2.1 China Pharmaceutical Group Corporation Corporation Information
11.2.2 China Pharmaceutical Group Corporation Description, Business Overview and Total Revenue
11.2.3 China Pharmaceutical Group Corporation Sales, Revenue and Gross Margin (2015-2020)
11.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Products Offered
11.2.5 China Pharmaceutical Group Corporation Recent Development
11.3 Guangzhou Pharmaceutical Group Co., Ltd.
11.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
11.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.3.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Development
11.4 Tianjin Pharmaceutical Group Co., Ltd.
11.4.1 Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
11.4.2 Tianjin Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.4.3 Tianjin Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Development
11.5 Harbin Pharmaceutical Group Co., Ltd
11.5.1 Harbin Pharmaceutical Group Co., Ltd Corporation Information
11.5.2 Harbin Pharmaceutical Group Co., Ltd Description, Business Overview and Total Revenue
11.5.3 Harbin Pharmaceutical Group Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Products Offered
11.5.5 Harbin Pharmaceutical Group Co., Ltd Recent Development
11.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
11.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
11.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description, Business Overview and Total Revenue
11.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Products Offered
11.6.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development
11.7 North China Pharmaceutical Group Co., Ltd.
11.7.1 North China Pharmaceutical Group Co., Ltd. Corporation Information
11.7.2 North China Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.7.3 North China Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.7.5 North China Pharmaceutical Group Co., Ltd. Recent Development
11.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
11.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
11.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.8.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development
11.9 Taiji Group Co., Ltd.
11.9.1 Taiji Group Co., Ltd. Corporation Information
11.9.2 Taiji Group Co., Ltd. Description, Business Overview and Total Revenue
11.9.3 Taiji Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Taiji Group Co., Ltd. Chinese Patent Medicine Products Offered
11.9.5 Taiji Group Co., Ltd. Recent Development
11.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
11.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
11.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.10.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development
11.1 Shanghai Pharmaceutical (Group) Co., Ltd.
11.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
11.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Description, Business Overview and Total Revenue
11.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Products Offered
11.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development
11.12 Chongqing Pharmaceutical Co., Ltd
11.12.1 Chongqing Pharmaceutical Co., Ltd Corporation Information
11.12.2 Chongqing Pharmaceutical Co., Ltd Description, Business Overview and Total Revenue
11.12.3 Chongqing Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Chongqing Pharmaceutical Co., Ltd Products Offered
11.12.5 Chongqing Pharmaceutical Co., Ltd Recent Development
11.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
11.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
11.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Products Offered
11.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development
11.14 Jiangxi Pharmaceutical Group Corporation
11.14.1 Jiangxi Pharmaceutical Group Corporation Corporation Information
11.14.2 Jiangxi Pharmaceutical Group Corporation Description, Business Overview and Total Revenue
11.14.3 Jiangxi Pharmaceutical Group Corporation Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Jiangxi Pharmaceutical Group Corporation Products Offered
11.14.5 Jiangxi Pharmaceutical Group Corporation Recent Development
11.15 Shijiazhuang Pharmaceutical Group Co., Ltd.
11.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
11.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Products Offered
11.15.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development
11.16 Northeast Pharmaceutical Group Co., Ltd.
11.16.1 Northeast Pharmaceutical Group Co., Ltd. Corporation Information
11.16.2 Northeast Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.16.3 Northeast Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Northeast Pharmaceutical Group Co., Ltd. Products Offered
11.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Chinese Patent Medicine Market Estimates and Projections by Region
12.1.1 Global Chinese Patent Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Chinese Patent Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Chinese Patent Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Chinese Patent Medicine Sales Forecast (2021-2026)
12.2.2 North America: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Chinese Patent Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Chinese Patent Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Chinese Patent Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Chinese Patent Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chinese Patent Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chinese Patent Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chinese Patent Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Chinese Patent Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Chinese Patent Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Chinese Patent Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chinese Patent Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chinese Patent Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chinese Patent Medicine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chinese Patent Medicine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Chinese Patent Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Chinese Patent Medicine Product Introduction
1.2 Market Segments
1.3 Key Chinese Patent Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chinese Patent Medicine Market Size Growth Rate by Type
1.4.2 Syrup
1.4.3 Liquid
1.4.4 Tablet
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chinese Patent Medicine Market Size Growth Rate by Application
1.5.2 Online Sales
1.5.3 Offline Sales
1.6 Coronavirus Disease 2019 (Covid-19): Chinese Patent Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Chinese Patent Medicine Industry
1.6.1.1 Chinese Patent Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chinese Patent Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chinese Patent Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Chinese Patent Medicine Market Size Estimates and Forecasts
2.1.1 Global Chinese Patent Medicine Revenue 2015-2026
2.1.2 Global Chinese Patent Medicine Sales 2015-2026
2.2 Chinese Patent Medicine Market Size by Region: 2020 Versus 2026
2.2.1 Global Chinese Patent Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chinese Patent Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL CHINESE PATENT MEDICINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Chinese Patent Medicine Sales by Manufacturers
3.1.1 Chinese Patent Medicine Sales by Manufacturers (2015-2020)
3.1.2 Chinese Patent Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Chinese Patent Medicine Revenue by Manufacturers
3.2.1 Chinese Patent Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Chinese Patent Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chinese Patent Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chinese Patent Medicine Revenue in 2019
3.2.5 Global Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chinese Patent Medicine Price by Manufacturers
3.4 Chinese Patent Medicine Manufacturing Base Distribution, Product Types
3.4.1 Chinese Patent Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chinese Patent Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Chinese Patent Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Chinese Patent Medicine Market Size by Type (2015-2020)
4.1.1 Global Chinese Patent Medicine Sales by Type (2015-2020)
4.1.2 Global Chinese Patent Medicine Revenue by Type (2015-2020)
4.1.3 Chinese Patent Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chinese Patent Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Chinese Patent Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Chinese Patent Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Chinese Patent Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chinese Patent Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Chinese Patent Medicine Market Size by Application (2015-2020)
5.1.1 Global Chinese Patent Medicine Sales by Application (2015-2020)
5.1.2 Global Chinese Patent Medicine Revenue by Application (2015-2020)
5.1.3 Chinese Patent Medicine Price by Application (2015-2020)
5.2 Chinese Patent Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Chinese Patent Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Chinese Patent Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Chinese Patent Medicine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Chinese Patent Medicine by Country
6.1.1 North America Chinese Patent Medicine Sales by Country
6.1.2 North America Chinese Patent Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chinese Patent Medicine Market Facts & Figures by Type
6.3 North America Chinese Patent Medicine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Chinese Patent Medicine by Country
7.1.1 Europe Chinese Patent Medicine Sales by Country
7.1.2 Europe Chinese Patent Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chinese Patent Medicine Market Facts & Figures by Type
7.3 Europe Chinese Patent Medicine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Chinese Patent Medicine by Region
8.1.1 Asia Pacific Chinese Patent Medicine Sales by Region
8.1.2 Asia Pacific Chinese Patent Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chinese Patent Medicine Market Facts & Figures by Type
8.3 Asia Pacific Chinese Patent Medicine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Chinese Patent Medicine by Country
9.1.1 Latin America Chinese Patent Medicine Sales by Country
9.1.2 Latin America Chinese Patent Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chinese Patent Medicine Market Facts & Figures by Type
9.3 Central & South America Chinese Patent Medicine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Chinese Patent Medicine by Country
10.1.1 Middle East and Africa Chinese Patent Medicine Sales by Country
10.1.2 Middle East and Africa Chinese Patent Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chinese Patent Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Chinese Patent Medicine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Shanghai Pharmaceutical (Group) Co., Ltd.
11.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
11.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Description, Business Overview and Total Revenue
11.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Products Offered
11.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development
11.2 China Pharmaceutical Group Corporation
11.2.1 China Pharmaceutical Group Corporation Corporation Information
11.2.2 China Pharmaceutical Group Corporation Description, Business Overview and Total Revenue
11.2.3 China Pharmaceutical Group Corporation Sales, Revenue and Gross Margin (2015-2020)
11.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Products Offered
11.2.5 China Pharmaceutical Group Corporation Recent Development
11.3 Guangzhou Pharmaceutical Group Co., Ltd.
11.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
11.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.3.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Development
11.4 Tianjin Pharmaceutical Group Co., Ltd.
11.4.1 Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
11.4.2 Tianjin Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.4.3 Tianjin Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Development
11.5 Harbin Pharmaceutical Group Co., Ltd
11.5.1 Harbin Pharmaceutical Group Co., Ltd Corporation Information
11.5.2 Harbin Pharmaceutical Group Co., Ltd Description, Business Overview and Total Revenue
11.5.3 Harbin Pharmaceutical Group Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Products Offered
11.5.5 Harbin Pharmaceutical Group Co., Ltd Recent Development
11.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
11.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
11.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description, Business Overview and Total Revenue
11.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Products Offered
11.6.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development
11.7 North China Pharmaceutical Group Co., Ltd.
11.7.1 North China Pharmaceutical Group Co., Ltd. Corporation Information
11.7.2 North China Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.7.3 North China Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.7.5 North China Pharmaceutical Group Co., Ltd. Recent Development
11.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
11.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
11.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.8.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development
11.9 Taiji Group Co., Ltd.
11.9.1 Taiji Group Co., Ltd. Corporation Information
11.9.2 Taiji Group Co., Ltd. Description, Business Overview and Total Revenue
11.9.3 Taiji Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Taiji Group Co., Ltd. Chinese Patent Medicine Products Offered
11.9.5 Taiji Group Co., Ltd. Recent Development
11.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
11.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
11.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Products Offered
11.10.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development
11.1 Shanghai Pharmaceutical (Group) Co., Ltd.
11.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
11.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Description, Business Overview and Total Revenue
11.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Products Offered
11.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development
11.12 Chongqing Pharmaceutical Co., Ltd
11.12.1 Chongqing Pharmaceutical Co., Ltd Corporation Information
11.12.2 Chongqing Pharmaceutical Co., Ltd Description, Business Overview and Total Revenue
11.12.3 Chongqing Pharmaceutical Co., Ltd Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Chongqing Pharmaceutical Co., Ltd Products Offered
11.12.5 Chongqing Pharmaceutical Co., Ltd Recent Development
11.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
11.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
11.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Products Offered
11.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development
11.14 Jiangxi Pharmaceutical Group Corporation
11.14.1 Jiangxi Pharmaceutical Group Corporation Corporation Information
11.14.2 Jiangxi Pharmaceutical Group Corporation Description, Business Overview and Total Revenue
11.14.3 Jiangxi Pharmaceutical Group Corporation Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Jiangxi Pharmaceutical Group Corporation Products Offered
11.14.5 Jiangxi Pharmaceutical Group Corporation Recent Development
11.15 Shijiazhuang Pharmaceutical Group Co., Ltd.
11.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
11.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Products Offered
11.15.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development
11.16 Northeast Pharmaceutical Group Co., Ltd.
11.16.1 Northeast Pharmaceutical Group Co., Ltd. Corporation Information
11.16.2 Northeast Pharmaceutical Group Co., Ltd. Description, Business Overview and Total Revenue
11.16.3 Northeast Pharmaceutical Group Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Northeast Pharmaceutical Group Co., Ltd. Products Offered
11.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Chinese Patent Medicine Market Estimates and Projections by Region
12.1.1 Global Chinese Patent Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Chinese Patent Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Chinese Patent Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Chinese Patent Medicine Sales Forecast (2021-2026)
12.2.2 North America: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Chinese Patent Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Chinese Patent Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Chinese Patent Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Chinese Patent Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chinese Patent Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chinese Patent Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chinese Patent Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Chinese Patent Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Chinese Patent Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Chinese Patent Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chinese Patent Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chinese Patent Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chinese Patent Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chinese Patent Medicine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chinese Patent Medicine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Chinese Patent Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Chinese Patent Medicine Market Segments
Table 2. Ranking of Global Top Chinese Patent Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chinese Patent Medicine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Syrup
Table 5. Major Manufacturers of Liquid
Table 6. Major Manufacturers of Tablet
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Chinese Patent Medicine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Chinese Patent Medicine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Chinese Patent Medicine Players to Combat Covid-19 Impact
Table 13. Global Chinese Patent Medicine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Chinese Patent Medicine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Chinese Patent Medicine Sales by Regions 2015-2020 (K MT)
Table 16. Global Chinese Patent Medicine Sales Market Share by Regions (2015-2020)
Table 17. Global Chinese Patent Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Chinese Patent Medicine Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Chinese Patent Medicine Sales Share by Manufacturers (2015-2020)
Table 20. Global Chinese Patent Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chinese Patent Medicine as of 2019)
Table 22. Chinese Patent Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Chinese Patent Medicine Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Chinese Patent Medicine Price (2015-2020) (USD/MT)
Table 25. Chinese Patent Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Chinese Patent Medicine Product Type
Table 27. Date of International Manufacturers Enter into Chinese Patent Medicine Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 30. Global Chinese Patent Medicine Sales Share by Type (2015-2020)
Table 31. Global Chinese Patent Medicine Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Chinese Patent Medicine Revenue Share by Type (2015-2020)
Table 33. Chinese Patent Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 35. Global Chinese Patent Medicine Sales Share by Application (2015-2020)
Table 36. North America Chinese Patent Medicine Sales by Country (2015-2020) (K MT)
Table 37. North America Chinese Patent Medicine Sales Market Share by Country (2015-2020)
Table 38. North America Chinese Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Chinese Patent Medicine Revenue Market Share by Country (2015-2020)
Table 40. North America Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 41. North America Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 42. North America Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 43. North America Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 44. Europe Chinese Patent Medicine Sales by Country (2015-2020) (K MT)
Table 45. Europe Chinese Patent Medicine Sales Market Share by Country (2015-2020)
Table 46. Europe Chinese Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Chinese Patent Medicine Revenue Market Share by Country (2015-2020)
Table 48. Europe Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 49. Europe Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 50. Europe Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 51. Europe Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Chinese Patent Medicine Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Chinese Patent Medicine Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Chinese Patent Medicine Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Chinese Patent Medicine Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 60. Latin America Chinese Patent Medicine Sales by Country (2015-2020) (K MT)
Table 61. Latin America Chinese Patent Medicine Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Chinese Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Chinese Patent Medicine Revenue Market Share by Country (2015-2020)
Table 64. Latin America Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 65. Latin America Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 66. Latin America Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 67. Latin America Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Chinese Patent Medicine Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Chinese Patent Medicine Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Chinese Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Chinese Patent Medicine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 76. Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 77. Shanghai Pharmaceutical (Group) Co., Ltd. Description and Major Businesses
Table 78. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Shanghai Pharmaceutical (Group) Co., Ltd. Product
Table 80. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development
Table 81. China Pharmaceutical Group Corporation Corporation Information
Table 82. China Pharmaceutical Group Corporation Description and Major Businesses
Table 83. China Pharmaceutical Group Corporation Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. China Pharmaceutical Group Corporation Product
Table 85. China Pharmaceutical Group Corporation Recent Development
Table 86. Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
Table 87. Guangzhou Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 88. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Guangzhou Pharmaceutical Group Co., Ltd. Product
Table 90. Guangzhou Pharmaceutical Group Co., Ltd. Recent Development
Table 91. Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
Table 92. Tianjin Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 93. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Tianjin Pharmaceutical Group Co., Ltd. Product
Table 95. Tianjin Pharmaceutical Group Co., Ltd. Recent Development
Table 96. Harbin Pharmaceutical Group Co., Ltd Corporation Information
Table 97. Harbin Pharmaceutical Group Co., Ltd Description and Major Businesses
Table 98. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Harbin Pharmaceutical Group Co., Ltd Product
Table 100. Harbin Pharmaceutical Group Co., Ltd Recent Development
Table 101. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
Table 102. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Major Businesses
Table 103. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Product
Table 105. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development
Table 106. North China Pharmaceutical Group Co., Ltd. Corporation Information
Table 107. North China Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 108. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. North China Pharmaceutical Group Co., Ltd. Product
Table 110. North China Pharmaceutical Group Co., Ltd. Recent Development
Table 111. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
Table 112. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 113. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Product
Table 115. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development
Table 116. Taiji Group Co., Ltd. Corporation Information
Table 117. Taiji Group Co., Ltd. Description and Major Businesses
Table 118. Taiji Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Taiji Group Co., Ltd. Product
Table 120. Taiji Group Co., Ltd. Recent Development
Table 121. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
Table 122. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 123. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Product
Table 125. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development
Table 126. Nanjing Pharmaceutical Co., Ltd Corporation Information
Table 127. Nanjing Pharmaceutical Co., Ltd Description and Major Businesses
Table 128. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Nanjing Pharmaceutical Co., Ltd Product
Table 130. Nanjing Pharmaceutical Co., Ltd Recent Development
Table 131. Chongqing Pharmaceutical Co., Ltd Corporation Information
Table 132. Chongqing Pharmaceutical Co., Ltd Description and Major Businesses
Table 133. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Chongqing Pharmaceutical Co., Ltd Product
Table 135. Chongqing Pharmaceutical Co., Ltd Recent Development
Table 136. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
Table 137. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 138. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Product
Table 140. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development
Table 141. Jiangxi Pharmaceutical Group Corporation Corporation Information
Table 142. Jiangxi Pharmaceutical Group Corporation Description and Major Businesses
Table 143. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. Jiangxi Pharmaceutical Group Corporation Product
Table 145. Jiangxi Pharmaceutical Group Corporation Recent Development
Table 146. Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
Table 147. Shijiazhuang Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 148. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 149. Shijiazhuang Pharmaceutical Group Co., Ltd. Product
Table 150. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development
Table 151. Northeast Pharmaceutical Group Co., Ltd. Corporation Information
Table 152. Northeast Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 153. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 154. Northeast Pharmaceutical Group Co., Ltd. Product
Table 155. Northeast Pharmaceutical Group Co., Ltd. Recent Development
Table 156. Global Chinese Patent Medicine Sales Forecast by Regions (2021-2026) (K MT)
Table 157. Global Chinese Patent Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 158. Global Chinese Patent Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 159. Global Chinese Patent Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 160. North America: Chinese Patent Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 161. North America: Chinese Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Europe: Chinese Patent Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 163. Europe: Chinese Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Asia Pacific: Chinese Patent Medicine Sales Forecast by Region (2021-2026) (K MT)
Table 165. Asia Pacific: Chinese Patent Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 166. Latin America: Chinese Patent Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 167. Latin America: Chinese Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Middle East and Africa: Chinese Patent Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 169. Middle East and Africa: Chinese Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 171. Key Challenges
Table 172. Market Risks
Table 173. Main Points Interviewed from Key Chinese Patent Medicine Players
Table 174. Chinese Patent Medicine Customers List
Table 175. Chinese Patent Medicine Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
Table 1. Chinese Patent Medicine Market Segments
Table 2. Ranking of Global Top Chinese Patent Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chinese Patent Medicine Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Syrup
Table 5. Major Manufacturers of Liquid
Table 6. Major Manufacturers of Tablet
Table 7. Major Manufacturers of Others
Table 8. COVID-19 Impact Global Market: (Four Chinese Patent Medicine Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Chinese Patent Medicine Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Chinese Patent Medicine Players to Combat Covid-19 Impact
Table 13. Global Chinese Patent Medicine Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Chinese Patent Medicine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Chinese Patent Medicine Sales by Regions 2015-2020 (K MT)
Table 16. Global Chinese Patent Medicine Sales Market Share by Regions (2015-2020)
Table 17. Global Chinese Patent Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Chinese Patent Medicine Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Chinese Patent Medicine Sales Share by Manufacturers (2015-2020)
Table 20. Global Chinese Patent Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chinese Patent Medicine as of 2019)
Table 22. Chinese Patent Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Chinese Patent Medicine Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Chinese Patent Medicine Price (2015-2020) (USD/MT)
Table 25. Chinese Patent Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Chinese Patent Medicine Product Type
Table 27. Date of International Manufacturers Enter into Chinese Patent Medicine Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 30. Global Chinese Patent Medicine Sales Share by Type (2015-2020)
Table 31. Global Chinese Patent Medicine Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Chinese Patent Medicine Revenue Share by Type (2015-2020)
Table 33. Chinese Patent Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 35. Global Chinese Patent Medicine Sales Share by Application (2015-2020)
Table 36. North America Chinese Patent Medicine Sales by Country (2015-2020) (K MT)
Table 37. North America Chinese Patent Medicine Sales Market Share by Country (2015-2020)
Table 38. North America Chinese Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Chinese Patent Medicine Revenue Market Share by Country (2015-2020)
Table 40. North America Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 41. North America Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 42. North America Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 43. North America Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 44. Europe Chinese Patent Medicine Sales by Country (2015-2020) (K MT)
Table 45. Europe Chinese Patent Medicine Sales Market Share by Country (2015-2020)
Table 46. Europe Chinese Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Chinese Patent Medicine Revenue Market Share by Country (2015-2020)
Table 48. Europe Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 49. Europe Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 50. Europe Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 51. Europe Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Chinese Patent Medicine Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Chinese Patent Medicine Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Chinese Patent Medicine Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Chinese Patent Medicine Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 60. Latin America Chinese Patent Medicine Sales by Country (2015-2020) (K MT)
Table 61. Latin America Chinese Patent Medicine Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Chinese Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Chinese Patent Medicine Revenue Market Share by Country (2015-2020)
Table 64. Latin America Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 65. Latin America Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 66. Latin America Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 67. Latin America Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Chinese Patent Medicine Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Chinese Patent Medicine Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Chinese Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Chinese Patent Medicine Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Chinese Patent Medicine Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Chinese Patent Medicine Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Table 76. Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information
Table 77. Shanghai Pharmaceutical (Group) Co., Ltd. Description and Major Businesses
Table 78. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Shanghai Pharmaceutical (Group) Co., Ltd. Product
Table 80. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development
Table 81. China Pharmaceutical Group Corporation Corporation Information
Table 82. China Pharmaceutical Group Corporation Description and Major Businesses
Table 83. China Pharmaceutical Group Corporation Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. China Pharmaceutical Group Corporation Product
Table 85. China Pharmaceutical Group Corporation Recent Development
Table 86. Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information
Table 87. Guangzhou Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 88. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Guangzhou Pharmaceutical Group Co., Ltd. Product
Table 90. Guangzhou Pharmaceutical Group Co., Ltd. Recent Development
Table 91. Tianjin Pharmaceutical Group Co., Ltd. Corporation Information
Table 92. Tianjin Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 93. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Tianjin Pharmaceutical Group Co., Ltd. Product
Table 95. Tianjin Pharmaceutical Group Co., Ltd. Recent Development
Table 96. Harbin Pharmaceutical Group Co., Ltd Corporation Information
Table 97. Harbin Pharmaceutical Group Co., Ltd Description and Major Businesses
Table 98. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Harbin Pharmaceutical Group Co., Ltd Product
Table 100. Harbin Pharmaceutical Group Co., Ltd Recent Development
Table 101. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information
Table 102. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Major Businesses
Table 103. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Product
Table 105. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development
Table 106. North China Pharmaceutical Group Co., Ltd. Corporation Information
Table 107. North China Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 108. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. North China Pharmaceutical Group Co., Ltd. Product
Table 110. North China Pharmaceutical Group Co., Ltd. Recent Development
Table 111. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information
Table 112. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 113. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Product
Table 115. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development
Table 116. Taiji Group Co., Ltd. Corporation Information
Table 117. Taiji Group Co., Ltd. Description and Major Businesses
Table 118. Taiji Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Taiji Group Co., Ltd. Product
Table 120. Taiji Group Co., Ltd. Recent Development
Table 121. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information
Table 122. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 123. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Product
Table 125. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development
Table 126. Nanjing Pharmaceutical Co., Ltd Corporation Information
Table 127. Nanjing Pharmaceutical Co., Ltd Description and Major Businesses
Table 128. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Nanjing Pharmaceutical Co., Ltd Product
Table 130. Nanjing Pharmaceutical Co., Ltd Recent Development
Table 131. Chongqing Pharmaceutical Co., Ltd Corporation Information
Table 132. Chongqing Pharmaceutical Co., Ltd Description and Major Businesses
Table 133. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 134. Chongqing Pharmaceutical Co., Ltd Product
Table 135. Chongqing Pharmaceutical Co., Ltd Recent Development
Table 136. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information
Table 137. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 138. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 139. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Product
Table 140. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development
Table 141. Jiangxi Pharmaceutical Group Corporation Corporation Information
Table 142. Jiangxi Pharmaceutical Group Corporation Description and Major Businesses
Table 143. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 144. Jiangxi Pharmaceutical Group Corporation Product
Table 145. Jiangxi Pharmaceutical Group Corporation Recent Development
Table 146. Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information
Table 147. Shijiazhuang Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 148. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 149. Shijiazhuang Pharmaceutical Group Co., Ltd. Product
Table 150. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development
Table 151. Northeast Pharmaceutical Group Co., Ltd. Corporation Information
Table 152. Northeast Pharmaceutical Group Co., Ltd. Description and Major Businesses
Table 153. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 154. Northeast Pharmaceutical Group Co., Ltd. Product
Table 155. Northeast Pharmaceutical Group Co., Ltd. Recent Development
Table 156. Global Chinese Patent Medicine Sales Forecast by Regions (2021-2026) (K MT)
Table 157. Global Chinese Patent Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 158. Global Chinese Patent Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 159. Global Chinese Patent Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 160. North America: Chinese Patent Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 161. North America: Chinese Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Europe: Chinese Patent Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 163. Europe: Chinese Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Asia Pacific: Chinese Patent Medicine Sales Forecast by Region (2021-2026) (K MT)
Table 165. Asia Pacific: Chinese Patent Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 166. Latin America: Chinese Patent Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 167. Latin America: Chinese Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Middle East and Africa: Chinese Patent Medicine Sales Forecast by Country (2021-2026) (K MT)
Table 169. Middle East and Africa: Chinese Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 171. Key Challenges
Table 172. Market Risks
Table 173. Main Points Interviewed from Key Chinese Patent Medicine Players
Table 174. Chinese Patent Medicine Customers List
Table 175. Chinese Patent Medicine Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Chinese Patent Medicine Product Picture
Figure 2. Global Chinese Patent Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Syrup Product Picture
Figure 4. Liquid Product Picture
Figure 5. Tablet Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chinese Patent Medicine Sales Market Share by Application in 2020 & 2026
Figure 8. Online Sales
Figure 9. Offline Sales
Figure 10. Chinese Patent Medicine Report Years Considered
Figure 11. Global Chinese Patent Medicine Market Size 2015-2026 (US$ Million)
Figure 12. Global Chinese Patent Medicine Sales 2015-2026 (K MT)
Figure 13. Global Chinese Patent Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Chinese Patent Medicine Sales Market Share by Region (2015-2020)
Figure 15. Global Chinese Patent Medicine Sales Market Share by Region in 2019
Figure 16. Global Chinese Patent Medicine Revenue Market Share by Region (2015-2020)
Figure 17. Global Chinese Patent Medicine Revenue Market Share by Region in 2019
Figure 18. Global Chinese Patent Medicine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Chinese Patent Medicine Revenue in 2019
Figure 20. Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Figure 22. Global Chinese Patent Medicine Sales Market Share by Type in 2019
Figure 23. Global Chinese Patent Medicine Revenue Market Share by Type (2015-2020)
Figure 24. Global Chinese Patent Medicine Revenue Market Share by Type in 2019
Figure 25. Global Chinese Patent Medicine Market Share by Price Range (2015-2020)
Figure 26. Global Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Figure 27. Global Chinese Patent Medicine Sales Market Share by Application in 2019
Figure 28. Global Chinese Patent Medicine Revenue Market Share by Application (2015-2020)
Figure 29. Global Chinese Patent Medicine Revenue Market Share by Application in 2019
Figure 30. North America Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Chinese Patent Medicine Sales Market Share by Country in 2019
Figure 33. North America Chinese Patent Medicine Revenue Market Share by Country in 2019
Figure 34. U.S. Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Chinese Patent Medicine Market Share by Type in 2019
Figure 39. North America Chinese Patent Medicine Market Share by Application in 2019
Figure 40. Europe Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Chinese Patent Medicine Sales Market Share by Country in 2019
Figure 43. Europe Chinese Patent Medicine Revenue Market Share by Country in 2019
Figure 44. Germany Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Chinese Patent Medicine Market Share by Type in 2019
Figure 55. Europe Chinese Patent Medicine Market Share by Application in 2019
Figure 56. Asia Pacific Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Chinese Patent Medicine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Chinese Patent Medicine Revenue Market Share by Region in 2019
Figure 60. China Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Chinese Patent Medicine Market Share by Type in 2019
Figure 83. Asia Pacific Chinese Patent Medicine Market Share by Application in 2019
Figure 84. Latin America Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Chinese Patent Medicine Sales Market Share by Country in 2019
Figure 87. Latin America Chinese Patent Medicine Revenue Market Share by Country in 2019
Figure 88. Mexico Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Chinese Patent Medicine Market Share by Type in 2019
Figure 95. Latin America Chinese Patent Medicine Market Share by Application in 2019
Figure 96. Middle East and Africa Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Chinese Patent Medicine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Chinese Patent Medicine Revenue Market Share by Country in 2019
Figure 100. Turkey Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Chinese Patent Medicine Market Share by Type in 2019
Figure 107. Middle East and Africa Chinese Patent Medicine Market Share by Application in 2019
Figure 108. Shanghai Pharmaceutical (Group) Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. China Pharmaceutical Group Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Guangzhou Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Tianjin Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Harbin Pharmaceutical Group Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North China Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Taiji Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Nanjing Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Chongqing Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Jiangxi Pharmaceutical Group Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Shijiazhuang Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Northeast Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. North America Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. North America Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Europe Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Europe Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Asia Pacific Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Asia Pacific Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Latin America Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 131. Latin America Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Middle East and Africa Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 133. Middle East and Africa Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Porter's Five Forces Analysis
Figure 135. Channels of Distribution
Figure 136. Distributors Profiles
Figure 137. Bottom-up and Top-down Approaches for This Report
Figure 138. Data Triangulation
Figure 139. Key Executives Interviewed
Figure 1. Chinese Patent Medicine Product Picture
Figure 2. Global Chinese Patent Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Syrup Product Picture
Figure 4. Liquid Product Picture
Figure 5. Tablet Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chinese Patent Medicine Sales Market Share by Application in 2020 & 2026
Figure 8. Online Sales
Figure 9. Offline Sales
Figure 10. Chinese Patent Medicine Report Years Considered
Figure 11. Global Chinese Patent Medicine Market Size 2015-2026 (US$ Million)
Figure 12. Global Chinese Patent Medicine Sales 2015-2026 (K MT)
Figure 13. Global Chinese Patent Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Chinese Patent Medicine Sales Market Share by Region (2015-2020)
Figure 15. Global Chinese Patent Medicine Sales Market Share by Region in 2019
Figure 16. Global Chinese Patent Medicine Revenue Market Share by Region (2015-2020)
Figure 17. Global Chinese Patent Medicine Revenue Market Share by Region in 2019
Figure 18. Global Chinese Patent Medicine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Chinese Patent Medicine Revenue in 2019
Figure 20. Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Chinese Patent Medicine Sales Market Share by Type (2015-2020)
Figure 22. Global Chinese Patent Medicine Sales Market Share by Type in 2019
Figure 23. Global Chinese Patent Medicine Revenue Market Share by Type (2015-2020)
Figure 24. Global Chinese Patent Medicine Revenue Market Share by Type in 2019
Figure 25. Global Chinese Patent Medicine Market Share by Price Range (2015-2020)
Figure 26. Global Chinese Patent Medicine Sales Market Share by Application (2015-2020)
Figure 27. Global Chinese Patent Medicine Sales Market Share by Application in 2019
Figure 28. Global Chinese Patent Medicine Revenue Market Share by Application (2015-2020)
Figure 29. Global Chinese Patent Medicine Revenue Market Share by Application in 2019
Figure 30. North America Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Chinese Patent Medicine Sales Market Share by Country in 2019
Figure 33. North America Chinese Patent Medicine Revenue Market Share by Country in 2019
Figure 34. U.S. Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Chinese Patent Medicine Market Share by Type in 2019
Figure 39. North America Chinese Patent Medicine Market Share by Application in 2019
Figure 40. Europe Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Chinese Patent Medicine Sales Market Share by Country in 2019
Figure 43. Europe Chinese Patent Medicine Revenue Market Share by Country in 2019
Figure 44. Germany Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Chinese Patent Medicine Market Share by Type in 2019
Figure 55. Europe Chinese Patent Medicine Market Share by Application in 2019
Figure 56. Asia Pacific Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Chinese Patent Medicine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Chinese Patent Medicine Revenue Market Share by Region in 2019
Figure 60. China Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Chinese Patent Medicine Market Share by Type in 2019
Figure 83. Asia Pacific Chinese Patent Medicine Market Share by Application in 2019
Figure 84. Latin America Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Chinese Patent Medicine Sales Market Share by Country in 2019
Figure 87. Latin America Chinese Patent Medicine Revenue Market Share by Country in 2019
Figure 88. Mexico Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Chinese Patent Medicine Market Share by Type in 2019
Figure 95. Latin America Chinese Patent Medicine Market Share by Application in 2019
Figure 96. Middle East and Africa Chinese Patent Medicine Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Chinese Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Chinese Patent Medicine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Chinese Patent Medicine Revenue Market Share by Country in 2019
Figure 100. Turkey Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Chinese Patent Medicine Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Chinese Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Chinese Patent Medicine Market Share by Type in 2019
Figure 107. Middle East and Africa Chinese Patent Medicine Market Share by Application in 2019
Figure 108. Shanghai Pharmaceutical (Group) Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. China Pharmaceutical Group Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Guangzhou Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Tianjin Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Harbin Pharmaceutical Group Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North China Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Taiji Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Nanjing Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Chongqing Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. Jiangxi Pharmaceutical Group Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 122. Shijiazhuang Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 123. Northeast Pharmaceutical Group Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 124. North America Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. North America Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Europe Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 127. Europe Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Asia Pacific Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 129. Asia Pacific Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Latin America Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 131. Latin America Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 132. Middle East and Africa Chinese Patent Medicine Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 133. Middle East and Africa Chinese Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 134. Porter's Five Forces Analysis
Figure 135. Channels of Distribution
Figure 136. Distributors Profiles
Figure 137. Bottom-up and Top-down Approaches for This Report
Figure 138. Data Triangulation
Figure 139. Key Executives Interviewed
